Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 5: Regulatory Integration of Diagnostic Markers and Therapeutic Trials

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Overview
David R. Parkinson, M.D.
Biogen Idec, San Diego, CA
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 14, 2006 10:30 AM-12:45 PM
The Critical Path Initiative: Goals of Molecular Diagnostics from FDA's Perspective
Janet Woodcock, M.D.
Food and Drug Administration, Rockville, MD
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 14, 2006 10:30 AM-12:45 PM
Pitfalls in Experimental Design and Data Analysis
Dr. Keith A. Baggerly
UT M. D. Anderson Cancer Center, Houston, TX
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 14, 2006 10:30 AM-12:45 PM
Moving from Correlative Studies to Predictive Medicine: How to Include Biomarkers in Clinical Trials
Dr. Richard M. Simon
National Cancer Institute, Bethesda, MD
from 2006 Molecular Diagnostics in Cancer Therapeutic Development conference on September 14, 2006 10:30 AM-12:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4